IKENA ONCOLOGY
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Sept 2025)
What this means for you
This application is over — abandoned 29 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98006735
- Mark type
- Stylized text
- Filed
- 22 May 2023
- Published for opposition
- 02 Jan 2024
- Abandoned
- 29 Sept 2025
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cancer and autoimmune diseases or disorders; Pharmaceutical preparations and substances for the treatment of oncological and immune system related diseases and disorders
Owner
- Ikena Oncology, Inc., Boston, MA, US
- Ikena Oncology, Inc., Boston, MA, US
Prior registrations
Prosecution history
- 29 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2025 — SOU EXTENSION 2 GRANTED
- 20 Feb 2025 — SOU EXTENSION 2 FILED
- 19 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2024 — SOU EXTENSION 1 GRANTED
- 06 Aug 2024 — SOU EXTENSION 1 FILED
- 06 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Jan 2024 — PUBLISHED FOR OPPOSITION
- 13 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER